Canada Markets open in 7 hrs 9 mins

Entheon Biomedical Corp. (ENTBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0220+0.0049 (+28.65%)
At close: 12:32PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.1900
52 Week Low 30.0100
50-Day Moving Average 30.0200
200-Day Moving Average 30.0372

Share Statistics

Avg Vol (3 month) 324.39k
Avg Vol (10 day) 36.43k
Shares Outstanding 559.09M
Implied Shares Outstanding 6N/A
Float 855.94M
% Held by Insiders 18.63%
% Held by Institutions 10.07%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 11, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Nov 29, 2021
Most Recent Quarter (mrq)May 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-17,504.79%

Management Effectiveness

Return on Assets (ttm)-51.41%
Return on Equity (ttm)-82.79%

Income Statement

Revenue (ttm)41.1k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)722.50%
Gross Profit (ttm)9.13k
Net Income Avi to Common (ttm)-6.73M
Diluted EPS (ttm)-0.1690
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)467.58k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)300k
Total Debt/Equity (mrq)4.79
Current Ratio (mrq)0.97
Book Value Per Share (mrq)0.17

Cash Flow Statement

Operating Cash Flow (ttm)-4.02M
Levered Free Cash Flow (ttm)-1.6M